• Conference Proceeding

Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination with Efavirenz Or Atazanavir/Ritonavir for Treatment-Naive Adults with Hiv-1 Infection in the United Kingdom

Citation

Wilkins, E., Fisher, M., Brogan, A., & Talbird, S. E. (2014). Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination with Efavirenz Or Atazanavir/Ritonavir for Treatment-Naive Adults with Hiv-1 Infection in the United Kingdom. In [17], pp. A276–A276. .

Abstract